window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : August 5, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

GMP Manufacturing

  • Advanced Therapies,Clinical & Regulatory,Manufacturing & Supply Chain

    CellProthera taps CELLforCURE by SEQENS for phase 3 production of heart attack cell therapy

    First clinical batches of ProtheraCytes expected in 2026 CellProthera has [...]

    May 5, 2026
  • Advanced Therapies

    Powerhouse partnership targets faster path to gene therapies

    eXmoor Pharma and KU Leuven team up to launch CGT [...]

    May 5, 2026
  • Biotech & Pharma Business

    RoosterBio and Thermo Fisher team up to accelerate cell and exosome therapy manufacturing

    May 5, 2026
  • Advanced Therapies

    Cellistic unveils Echo-NK platform to scale up iPSC-based cell therapies

    May 5, 2026
Previous23

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Clean Cells acquires Anaquant to expand mass spectrometry capabilities in biopharma quality control
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Research & Development
  • AB2 Bio receives $30 million as Nippon Shinyaku exercises US option for rare disease drug
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Causaly and Sage bring full-text scientific literature to AI drug discovery research
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top